Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer

NCT02391480 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02391480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02391480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Advanced Cancer
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
April 14, 2015
Completion date
July 5, 2019
Enrollment
128 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), breast cancer, cancer, multiple myeloma, non-hodgkins lymphoma, non-small cell lung cancer, prostate cancer, small cell lung cancer